Cost assessment in melanoma clinical trials: A cross-sectional study

Cost assessment in melanoma clinical trials: A cross-sectional study

Bibliographic Details
Main Authors:	Rachel S. Goodman, MBA, Desmond C. Garner, BS, Stefan Koester, BS, J. Randall Patrinely, Jr., MD, MBA, Anna K. Dewan, MD, Douglas B. Johnson, MD, MSCI
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	JAAD International
Subjects:	clinical trials cost cost effectiveness melanoma skin cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328723000779

Similar Items

The Prevalence and Treatment Costs of Non-Melanoma Skin Cancer in Cluj-Napoca Maxillofacial Center
by: Cosmin Ioan Faur, et al.
Published: (2023-01-01)

Cost items in melanoma patients by clinical characteristics and time from diagnosis
by: Alessandra Buja, et al.
Published: (2023-11-01)

MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection—Narrative Review
by: Agata Poniewierska-Baran, et al.
Published: (2023-03-01)

Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France
by: Marguerite Kandel, et al.
Published: (2022-11-01)

Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
by: Si Ni Li, et al.
Published: (2023-01-01)

Vitiligo-like amelanotic melanoma in situ: A rare presentation
by: Lilia Maria Lima de Oliveira, MD, et al.
Published: (2024-05-01)

Current Melanoma Treatments: Where Do We Stand?
by: Alvaro Moreira, et al.
Published: (2021-01-01)

Bilateral axillary pigmented lesions in a melanoma patient
by: Shannon Gurley, BS, et al.
Published: (2023-12-01)

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs
by: Brenda Leeneman, et al.
Published: (2020-04-01)

Desmoplastic melanoma presenting as an alopecic patch in a young patient
by: Lauren C. LaMonica, MPH, et al.
Published: (2023-08-01)

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
by: Ibrahim Ragab Eissa, et al.
Published: (2018-09-01)

Efficiency of criminal proceedings and their cost
by: Agnieszka Orfin
Published: (2022-12-01)

Prognostic gene expression profile testing to inform use of adjuvant therapy: A survey of melanoma experts
by: Suzanne Fastner, et al.
Published: (2023-12-01)

Economic evaluations performed alongside randomized implementation trials in clinical settings: a systematic review
by: Alayna Carrandi, et al.
Published: (2024-03-01)

Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice
by: Kristen E. Rhodin, et al.
Published: (2022-10-01)

Comparative Analysis of BIPV Solutions to Define Energy and Cost-Effectiveness in a Case Study
by: Paolo Corti, et al.
Published: (2020-07-01)

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
by: Brandon Lu, et al.
Published: (2023-05-01)

Determination of product costs
by: 348757 Johnson, T. F., et al.
Published: (19--)

Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances
by: Strahil Strashilov, et al.
Published: (2021-06-01)

The high cost of care and limited evidence on cost-effective strategies for Lewy body dementia: systematic review of evidence
by: Erin Boland, et al.
Published: (2024-01-01)

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma
by: Merve Hasanov, et al.
Published: (2020-08-01)

Unit Cost Perawatan Gigi di Klinik Fanisa Kota Pariaman dengan Metode Activity Based Costing
by: Hidayati Hidayati, et al.
Published: (2023-12-01)

Evaluating registry-based trial economics: Results from the STRESS clinical trial
by: Eric L. Eisenstein, et al.
Published: (2024-04-01)

Mass Customized Outlook for Regenerative Heart Failure Care
by: Satsuki Yamada, et al.
Published: (2021-10-01)

Approaches to prioritising research for clinical trial networks: a scoping review
by: Rachael L. Morton, et al.
Published: (2022-12-01)

Not Your Mother’s Melanoma: Causes and Effects of Early Melanoma Diagnosis
by: Kaviyon Sadrolashrafi, et al.
Published: (2022-11-01)

Cell Immunotherapy against Melanoma: Clinical Trials Review
by: Ivan Y. Filin, et al.
Published: (2023-01-01)

On the reimbursement of pre-trial costs in legal proceedings
by: Vicko Prančić
Published: (2010-01-01)

The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
by: Mariana Matias, et al.
Published: (2021-11-01)

Introductory study of critical success factors for activity based costing implementation in manufacturing industry /
by: 177501 Md. Mizreen Mohamed Sadek
Published: (2006)

Expected life cycle cost for systems with repairable components /
by: Ebrahimi, Amirhossein, 1980-, et al.
Published: (2013)

A typology of cost accounting practices based on activity-based costing - a strategic cost management approach / Gregory Wegmann
by: Wegmann, Gregory
Published: (2019)

Adjuvant Ipilimumab in High-Risk Uveal Melanoma
by: Eric Fountain, et al.
Published: (2019-01-01)

Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?
by: Hanna H. Kakish, et al.
Published: (2022-10-01)

The Diagnosis and Management of Cutaneous Metastases from Melanoma
by: Cosimo Di Raimondo, et al.
Published: (2023-09-01)

Association between Klotho protein and melanoma and nonmelanoma skin cancer in the US adult population: A cross-sectional study
by: Nargiza Sadr, BSN, MS2, et al.
Published: (2023-12-01)

Introductory study of critical success factors for activity based costing implementation in manufacturing industry [compact disc] /
by: 177501 Md. Mizreen Mohamed Sadek
Published: (2006)

The Thousand Faces of Malignant Melanoma: A Systematic Review of the Primary Malignant Melanoma of the Esophagus
by: Gerardo Cazzato, et al.
Published: (2022-07-01)

Intricacies of overhead cost allocations and distortion in costing: a synthesis of the literature / Bülend Terzioglu
by: Terzioglu, Bülend
Published: (2012)

Routine Histopathologic Examination of Bone Obtained During Elective Primary Total Knee Arthroplasty May Not Be Necessary
by: Colin McNamara, MD, MBA, et al.
Published: (2023-10-01)